A 10‐Year Follow‐Up of Reconstructive Treatment of Peri‐Implantitis Using Mineralized Dehydrated Allograft and Resorbable Membrane: A Retrospective Case Series
Clinical Oral Implants Research · 2025
DOI: 10.1111/clr.14385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Implants Research, 2025. Verfasst von Gerardo La Monaca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillo-Facial Sciences, Sapienza, University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Peri-Implantitis, Bone Transplantation, Membranes, Artificial, Absorbable Implants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the 10‐year clinical and radiographic outcomes of peri‐implantitis intrabony defects treated with mineralized dehydrated bone allograft (MDBA) and resorbable membrane in patients undergoing a regular supportive peri‐implant/periodontal therapy (STP). Materials and Methods The original study participants were 34 (34 defects). After mechanical debridement and chemical decontamination of implant surfaces, intrabony defects were filled with MDBA and covered by a resorbable membrane. Patients were enrolled in a maintenance program with a recall interval of 6 months. The primary outcome was the absence of additional marginal peri‐implant bone loss ≥ 1.0 mm after surgery. The composite outcome was no additional marginal peri‐implant bone loss ≥ 1.0 mm and the absence of probing depth (PD) ≥ 5 mm, bleeding on probing and suppuration.
Results
Of the original 34 implants, 20 completed the 10‐year follow‐up, and three failed. Related to the primary outcome, the mean peri‐implant marginal bone level changed from 4.78 mm (SD 1.84) at baseline to 3.10 mm (SD 1.73) after surgery and 3.71 mm (SD 1.78) at the follow‐up end point. According to the composite outcome for disease resolution, 19 of the 34 original implants were successfully treated at the 10‐year follow‐up with a statistically significant difference between 1 (31/34 implants) and 5 years (20/34 implants) ( p = 0.003) and 1 and 10 years ( p = 0.001) but not between 5 and 10 years ( p = 1.000).
Conclusions
Ten years after the reconstructive treatment, followed by regular SPT, the cumulative successful treatment rate, according to the primary and the composite outcomes, was 58% (20/34 implants) and 53% (19/34) implants, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillo-Facial Sciences, Sapienza, University of Rome, Rome, Italy.
ORCID-Profile: Gerardo La Monaca, Nicola Pranno, Susanna Annibali, Antonella Polimeni, Maria Paola Cristalli
Zitieren
APA
La Monaca, G., Pranno, N., Annibali, S., Polimeni, A., & Cristalli, M. P. (2025). A 10‐Year Follow‐Up of Reconstructive Treatment of Peri‐Implantitis Using Mineralized Dehydrated Allograft and Resorbable Membrane: A Retrospective Case Series. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14385
Vancouver
La Monaca G, Pranno N, Annibali S, Polimeni A, Cristalli MP. A 10‐Year Follow‐Up of Reconstructive Treatment of Peri‐Implantitis Using Mineralized Dehydrated Allograft and Resorbable Membrane: A Retrospective Case Series. Clinical Oral Implants Research. 2025. doi:10.1111/clr.14385
BibTeX
@article{LaMonaca2025,
author = {La Monaca, Gerardo and Pranno, Nicola and Annibali, Susanna and Polimeni, Antonella and Cristalli, Maria Paola},
title = {A 10‐Year Follow‐Up of Reconstructive Treatment of Peri‐Implantitis Using Mineralized Dehydrated Allograft and Resorbable Membrane: A Retrospective Case Series},
journal = {Clinical Oral Implants Research},
year = {2025},
doi = {10.1111/clr.14385}
}
EUVIMED